Bolandiol dipropionate
Bolandiol dipropionate, also known as nandrolone 3,17β-dipropionate, is a synthetic, injectable anabolic steroid and a derivative of testosterone. It is an ester of bolandiol (19-nor-4-androstenediol), specifically, the 3,17β-dipropionate ester. Bolandiol dipropionate acts as a prodrug of bolandiol in the body, meaning it is metabolized into active bolandiol after administration. This compound is known for its anabolic properties, which promote muscle growth and increase strength, making it of interest in the fields of medicine and sports, particularly in bodybuilding and athletics. However, its use is controversial due to potential health risks and ethical concerns regarding performance enhancement.
Medical Uses
Bolandiol dipropionate has been investigated for various medical applications, primarily for its potential in treating conditions associated with muscle wasting and osteoporosis. Due to its anabolic effects, it could potentially aid in the recovery of muscle mass in patients suffering from diseases that lead to muscle atrophy. However, its use in clinical settings is limited, and it is not widely recognized or approved for medical treatment in many countries.
Mechanism of Action
As a prodrug of bolandiol, bolandiol dipropionate exerts its effects through conversion to bolandiol within the body. Bolandiol then binds to and activates androgen receptors in skeletal muscle cells, leading to an increase in muscle protein synthesis and, consequently, muscle growth. Additionally, it may have effects on bone density, potentially beneficial in treating osteoporosis.
Side Effects
The use of bolandiol dipropionate, like other anabolic steroids, can lead to a range of adverse effects. These may include, but are not limited to, acne, gynecomastia (development of breast tissue in men), alterations in lipid profiles, liver toxicity, and changes in mood and behavior. Its androgenic effects also raise concerns regarding its impact on hormonal balance and the potential for virilization in women.
Legal Status
The legal status of bolandiol dipropionate varies by country, but it is generally classified as a controlled substance under various anti-doping regulations. Its use is prohibited in most competitive sports by organizations such as the World Anti-Doping Agency (WADA).
See Also
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
